Inhibition of EZH2 and immune signaling exerts synergistic antitumor effects in chronic lymphocytic leukemia. (Record no. 29824328)

MARC details
000 -LEADER
fixed length control field 02386 a2200637 4500
005 - DATE AND TIME OF LATEST TRANSACTION
control field 20250518044739.0
008 - FIXED-LENGTH DATA ELEMENTS--GENERAL INFORMATION
fixed length control field 202006s 0 0 eng d
022 ## - INTERNATIONAL STANDARD SERIAL NUMBER
International Standard Serial Number 2473-9537
024 7# - OTHER STANDARD IDENTIFIER
Standard number or code 10.1182/bloodadvances.2018030262
Source of number or code doi
040 ## - CATALOGING SOURCE
Original cataloging agency NLM
Language of cataloging eng
Transcribing agency NLM
100 1# - MAIN ENTRY--PERSONAL NAME
Personal name Chartomatsidou, Elisavet
264 #0 - PRODUCTION, PUBLICATION, DISTRIBUTION, MANUFACTURE, AND COPYRIGHT NOTICE
Date of production, publication, distribution, manufacture, or copyright notice 20200615
245 00 - TITLE STATEMENT
Title Inhibition of EZH2 and immune signaling exerts synergistic antitumor effects in chronic lymphocytic leukemia.
Medium [electronic resource]
260 ## - PUBLICATION, DISTRIBUTION, ETC.
Name of publisher, distributor, etc. Blood advances
Date of publication, distribution, etc. 06 2019
300 ## - PHYSICAL DESCRIPTION
Extent 1891-1896 p.
Other physical details digital
500 ## - GENERAL NOTE
General note Publication Type: Comparative Study; Journal Article; Research Support, Non-U.S. Gov't
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Adenine
General subdivision analogs & derivatives
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Antineoplastic Agents
General subdivision pharmacology
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Antineoplastic Combined Chemotherapy Protocols
General subdivision pharmacology
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Apoptosis
General subdivision drug effects
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element B-Lymphocytes
General subdivision drug effects
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Bridged Bicyclo Compounds, Heterocyclic
General subdivision pharmacology
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Down-Regulation
General subdivision drug effects
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Drug Synergism
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Enhancer of Zeste Homolog 2 Protein
General subdivision antagonists & inhibitors
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Enzyme Inhibitors
General subdivision pharmacology
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Histones
General subdivision drug effects
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Humans
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Indazoles
General subdivision pharmacology
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Indoles
General subdivision pharmacology
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Leukemia, Lymphocytic, Chronic, B-Cell
General subdivision blood
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Piperidines
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Purines
General subdivision pharmacology
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Pyrazoles
General subdivision pharmacology
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Pyridones
General subdivision pharmacology
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Pyrimidines
General subdivision pharmacology
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Quinazolinones
General subdivision pharmacology
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Signal Transduction
General subdivision drug effects
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Sulfonamides
General subdivision pharmacology
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Tumor Microenvironment
General subdivision drug effects
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Ntoufa, Stavroula
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Kotta, Konstantia
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Rovida, Alessandra
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Akritidou, Maria Anna
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Belloni, Daniela
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Ferrero, Elisabetta
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Trangas, Theoni
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Stavroyianni, Niki
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Anagnostopoulos, Achilles
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Rosenquist, Richard
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Ghia, Paolo
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Papakonstantinou, Nikos
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Stamatopoulos, Kostas
773 0# - HOST ITEM ENTRY
Title Blood advances
Related parts vol. 3
-- no. 12
-- p. 1891-1896
856 40 - ELECTRONIC LOCATION AND ACCESS
Uniform Resource Identifier <a href="https://doi.org/10.1182/bloodadvances.2018030262">https://doi.org/10.1182/bloodadvances.2018030262</a>
Public note Available from publisher's website

No items available.